Clinical utility of a competitive ELISA to detect antibodies against Treponema pallidum
- PMID: 10683619
- PMCID: PMC6808137
- DOI: 10.1002/(SICI)1098-2825(2000)14:2<83::AID-JCLA8>3.0.CO;2-A
Clinical utility of a competitive ELISA to detect antibodies against Treponema pallidum
Abstract
Screening for Treponema pallidum infection is carried out on a large human population. To reduce costs, fewer tests which still offer adequate sensitivity and specificity could be performed. We studied the reliability of a novel indirect ELISA method to test for this infection. Several panels of sera were used that corresponded to 40 primary infections (group 1), 13 recurrences (group 2), 348 latent infections (group 3), 5 samples with anticardiolipin antibodies (group 4), 15 samples from patients with Lyme borreliosis (group 5), and 400 samples from blood donors and healthy pregnant women (group 6). The ELISA showed a global sensitivity and specificity of 100 and 99.5%, respectively. Our evaluation shows that Enzygnost Syphilis is a sensitive, specific, and simple test to screen for this infection.
Copyright 2000 Wiley-Liss, Inc.
References
-
- Norris SJ, Larsen SA. Treponema and other host‐associated spirochetes In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. A.S.M; 1995. p 636–651.
-
- Young, H . Syphilis: new diagnostics directions. Int J STD AIDS 1992; 3: 391–413. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
